(Stroke. 2002;33:988.)
© 2002 American Heart Association, Inc.
Original Contributions |
From the Beth Israel Deaconess Medical Center (J.N.F., S.K., C.H., I.L., L.R.C., G.S.), Boston, and UMass Memorial Medical Center (M.H.S.), Worcester, Mass.
Correspondence to Gottfried Schlaug, MD, Assistant Professor of Neurology, Director of Neuroimaging, Stroke Division, Dana 779, Beth Israel Deaconess Medical Center, 330 Brookline Ave, Boston, MA 02215. E-mail gschlaug{at}caregroup.harvard.edu
Background and Purpose Time of stroke onset is uncertain for patients who wake from sleep with stroke. Functional imaging techniques may allow estimation of benefit and risk of acute stroke therapy. We compared the clinical and multimodal MRI findings of patients with uncertain stroke onset with those with known onset time.
Methods Patients imaged within 24 hours of ischemic stroke onset between January 1997 and June 2000 were identified from a prospective stroke registry. Clinical and imaging data from patients with known stroke onset (group I) were compared with those who woke with stroke (group II).
Results A total of 364 patients were identified, of whom 100 (27%) woke from sleep with stroke. Group I and group II did not differ in age, gender, National Institutes of Health Stroke Scale, or TOAST (Trial of Org 10172 in Acute Stroke Treatment) diagnoses. Time from stroke onset was shorter in group I (mean 6.0 versus 13.3 hours, P<0.001); time from detection did not differ between groups (6.0 versus 5.9 hours). Within 3 hours, diffusion-weighted imaging (DWI) and perfusion-weighted imaging (PWI) lesion volumes were similar in both groups; DWI-PWI mismatch was present in 82% of group I and 73% of group II patients. Mean apparent diffusion coefficient of water (ADC) of group I patients was negatively associated with DWI volume (ß=-0.324, P=0.004) and time from stroke onset (ß=-0.238, P=0.031) in multivariate analysis. The mean ADC of group II patients was lower than that of group I patients within 3 hours of stroke detection (mean 556 versus 665 µm2/s, P<0.01), but individual group II patients had ADC values as high as 742 µm2/s, in addition to a DWI-PWI mismatch pattern.
Conclusions Onset time is uncertain in over one quarter of acute ischemic stroke patients. Clinical features of these patients do not differ significantly from those with known onset time. Some patients who wake with stroke seem to have favorable imaging characteristics for acute stroke therapy. Further study is needed to determine whether criteria for therapy based on imaging parameters can safely be applied to these patients.
Key Words: cerebral infarction diagnosis magnetic resonance imaging
This article has been cited by other articles:
![]() |
C. Iosif, C. Oppenheim, D. Trystram, V. Domigo, and J.-F. Meder MR Imaging-Based Decision in Thrombolytic Therapy for Stroke on Awakening: Report of 2 Cases AJNR Am. J. Neuroradiol., August 1, 2008; 29(7): 1314 - 1316. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. P. Adams Jr, M. B. Effron, J. Torner, A. Davalos, J. Frayne, P. Teal, J. Leclerc, B. Oemar, L. Padgett, E. S. Barnathan, et al. Emergency Administration of Abciximab for Treatment of Patients With Acute Ischemic Stroke: Results of an International Phase III Trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II) Stroke, January 1, 2008; 39(1): 87 - 99. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Cramer, T. B. Parrish, R. M. Levy, G. T. Stebbins, S. D. Ruland, D. W. Lowry, T. P. Trouard, S. W. Squire, M. E. Weinand, C. R. Savage, et al. Predicting Functional Gains in a Stroke Trial Stroke, July 1, 2007; 38(7): 2108 - 2114. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Schiemanck, G. Kwakkel, M. W. M. Post, and A. J. H. Prevo Predictive Value of Ischemic Lesion Volume Assessed With Magnetic Resonance Imaging for Neurological Deficits and Functional Outcome Poststroke: A Critical Review of the Literature. Neurorehabil Neural Repair, December 1, 2006; 20(4): 492 - 502. [Abstract] [PDF] |
||||
![]() |
K D Hellier, J L Hampton, J V Guadagno, N P Higgins, N M Antoun, D J Day, J H Gillard, E A Warburton, and J-C Baron Perfusion CT helps decision making for thrombolysis when there is no clear time of onset. J. Neurol. Neurosurg. Psychiatry, March 1, 2006; 77(3): 417 - 419. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Alsop, E. Makovetskaya, S. Kumar, M. Selim, and G. Schlaug Markedly Reduced Apparent Blood Volume on Bolus Contrast Magnetic Resonance Imaging as a Predictor of Hemorrhage After Thrombolytic Therapy for Acute Ischemic Stroke Stroke, April 1, 2005; 36(4): 746 - 750. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Reineck, S. Agarwal, and A. E. Hillis "Diffusion-clinical mismatch" is associated with potential for early recovery of aphasia Neurology, March 8, 2005; 64(5): 828 - 833. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. Schellinger, J. B. Fiebach, W. Hacke, and J. Rother Imaging-Based Decision Making in Thrombolytic Therapy for Ischemic Stroke: Present Status Stroke, February 1, 2003; 34(2): 575 - 583. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |